Cite
Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell–matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis.
MLA
Chen, Yan, et al. “Estrogen and Pure Antiestrogen Fulvestrant (ICI 182 780) Augment Cell–matrigel Adhesion of MCF-7 Breast Cancer Cells through a Novel G Protein Coupled Estrogen Receptor (GPR30)-to-Calpain Signaling Axis.” Toxicology & Applied Pharmacology, vol. 275, no. 2, Mar. 2014, pp. 176–81. EBSCOhost, https://doi.org/10.1016/j.taap.2014.01.005.
APA
Chen, Y., Li, Z., He, Y., Shang, D., Pan, J., Wang, H., Chen, H., Zhu, Z., Wan, L., & Wang, X. (2014). Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell–matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicology & Applied Pharmacology, 275(2), 176–181. https://doi.org/10.1016/j.taap.2014.01.005
Chicago
Chen, Yan, Zheng Li, Yan He, Dandan Shang, Jigang Pan, Hongmei Wang, Huamei Chen, Zhuxia Zhu, Lei Wan, and Xudong Wang. 2014. “Estrogen and Pure Antiestrogen Fulvestrant (ICI 182 780) Augment Cell–matrigel Adhesion of MCF-7 Breast Cancer Cells through a Novel G Protein Coupled Estrogen Receptor (GPR30)-to-Calpain Signaling Axis.” Toxicology & Applied Pharmacology 275 (2): 176–81. doi:10.1016/j.taap.2014.01.005.